Cobenfy was approved by the Food and Drug Administration in fall 2024 and represents the first novel approach in decades to ...

Moreover, OPC-14597 shares some characteristics of other atypical antipsychotics with respect ... the known molecular isoforms of the dopamine receptors in several transfection systems, as well ...

In the months after 24-year-old D.J. was diagnosed with schizophrenia, he searched online for answers to questions that felt urgent and existential.

such as the 5-HT 1A receptor, are considered to mediate the ability of antipsychotic drugs to enhance cognition. On the other hand, treatment with some atypical agents, such as risperidone ...

Agitated patients are often prescribed antipsychotic medications and sedatives off-label, but this can pose a risk to the ...

All prior antipsychotics have, in large part, relied on blocking this chemical messenger’s receptors. Although they’re relatively effective at dimming hallucinations, antipsychotics struggle to manage ...

Tardive tics can be more than a momentary disruption. They can completely shake up your life, leading you to feel less ...

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S.

A large database study suggests that patients with primary dysautonomias face a significantly increased risk for seborrheic ...